Loading...
Loading...
TRINITY BIOTECH PLC
TRINITY BIOTECH PLC. Spoken Alpha tracks TRIB's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks TRIB's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 50% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 6 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for TRIB.
curl https://api.spokenalpha.com/v1/companies/TRIB| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $4.67 | $4.23 | +10.5% | +3.1% | +0.2% |
| Q4 FY2026 | $4.46 | $4.23 | +5.4% | +1.3% | +3.6% |
| Q3 FY2026 | $4.75 | $4.37 | +8.6% | -5.4% | -2.7% |
| Q2 FY2026 | $4.42 | $4.23 | +4.4% | -6.1% | -5.0% |
| Q1 FY2025 | $4.61 | $4.38 | +5.3% | -1.4% | +0.6% |
| Q4 FY2025 | $4.77 | $4.31 | +10.6% | +0.3% | -1.5% |
| Q3 FY2025 | $4.40 | $4.30 | +2.4% | +5.0% | +3.2% |
| Q2 FY2025 | $4.54 | $4.28 | +6.1% | -5.7% | -6.6% |
| Q1 FY2024 | $4.72 | $4.48 | +5.4% | -3.1% | -5.9% |
| Q4 FY2024 | $4.76 | $4.46 | +6.8% | +2.7% | +2.0% |